Highly effective tumor ablation
SDRT shows excellent rates of tumor ablation that can be completed in same day as planning.
Lower Incidence of Side Effects
No need for surgery or long stays in treatment, patients get their quality of life back without long recovery times.
Reduced Investment of Care
Minimize the amount time needed for travel, treatment, regular appointments & continual follow-ups. Giving patients their time back.
Avoid Surgery Entirely
Treatment is minimally invasive to the body, meaning that it is accessible to even elderly patients who are at increased risk due to surgery.
SDRT is a disruptive treatment that will change the standard of cancer care, ablating an unprecedented >90% of human solid tumors. Allowing patients to avoid surgery altogether and without the need for multiple sessions.
One Shot, Two Targets
Current Treatments
SDRT is a cutting-edge cancer treatment, compared to current fractionated radiotherapy. Ceramedix offers treatments for many prevalent types of Cancer, and is constantly looking to apply it to others in the future.
Fractionated
(SBRT)
-
Tumor Ablation rates ~38%
-
Treatment takes 2-5 sessions over 1-2 week period (typically)
-
Depending on treatment and level of cancer, may require invasive surgery
SDRT
-
Tumor Ablation >90% regardless of tumor type
-
Treatment can be completed same day as planning
-
No need for surgery, and minimal side effects from treatement
Prostate Cancer
Breast Cancer
Pancreatic Cancer
Oligometastatic disease
Please fill out the form above and a member of our team will be in touch with you to schedule a consultation.
-
A temporary disruption of tumor blood flow results in an acute reduction of oxygen perfusion throughout the tumor tissue (“ischemic phase hypoxia”)
-
Hypoxia injures the mitochondrial respiratory chain system in tumor cells and inevitably causes diffuse damage to the metabolic function of the cell via generation of reactive oxygen species (ROS)
-
In response, the tumor cells activate a rescue operation, termed “SUMO Stress Response” (SSR)
-
An element of SSR is transient silencing of normal cellular functions, such as the assembly and activation of homology-driven repair (HDR) of DSBs, an adaptive cell lethality function activated by exposure to SDRT
-
A global loss of both HDR and repair of DSBs leads to extensive DNA disintegration in tumor cells, generalized tumor cell death, and tumor ablation
Winter Park Treatment Center Equipment
Powered by
Varian Edge™
The Varian Edge System provides our team state of the art technology. With unparralleled precision that makes it possible to deliver ultra-high doses of radiation, without hurting nearby healthy tissue.
This advanced new technique, SDRT, was developed at Memoiral Sloan-Kettering Cancer Center, by one of our Founder Physicians, Dr. Zvi Fuchs.
Medical Evidence:
Below you can find journals published by some of our Founding Medical Partners.
Bodo et al.; J Clin Invest. (2019) 129:786-801
Greco et al.; Int J Radiation Oncol Biol Phys (2021) ; 109:288-297
Greco et al.; JAMA Oncol. (2021) 7:700-708
Greco and Fuks: JAMA Oncology (2020) 6: 659-660
Zelefsky et al.; Int J Radiation Oncol Biol Phys, (2012) 110:672-679
